You are here

Novo Nordisk

Novo bets up to $354M per target on Gensaic’s tissue-selective delivery tech

Fierce Biotech

Mon, 03/3/25 - 10:52 am

artificial intelligence

Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4

Fierce Pharma

Mon, 02/24/25 - 11:09 am

Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows

CNBC

Fri, 02/21/25 - 10:48 am

Insurers push back on Medicare and Medicaid coverage for GLP-1s

Axios

Thu, 02/20/25 - 11:37 am

Novo seeks $830M in fraud case against Singaporean biotech over kidney drug

BioSpace

Tue, 02/18/25 - 11:13 am

KBP Biosciences

First biosimilar fast-acting insulin reaches US market

Pharmaphorum

Tue, 02/18/25 - 09:47 am

Ozempic Shows Some Promise for Alcohol Use Disorder

US News and World Report

Wed, 02/12/25 - 09:26 pm

alcohol-use disorder

Wegovy and Ozempic stars dim amid overuse concerns

Axios

Tue, 02/11/25 - 11:17 am

Novo Nordisk plans new study for CagriSema, targets 2026 submission

Clinical Trials Arena

Fri, 02/7/25 - 11:42 am

clinical trials

Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect

Fierce Biotech

Fri, 02/7/25 - 11:02 am

Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned

Yahoo/Reuters

Thu, 02/6/25 - 11:40 am

Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump

CNBC

Wed, 02/5/25 - 10:42 pm

Novo flunks kidney disease trial, again linking obesity prospect to neuropsychiatric side effects

Fierce Biotech

Wed, 02/5/25 - 11:21 am

clinical trials

diabetic kidney disease

Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema

Yahoo/Reuters

Tue, 02/4/25 - 06:11 pm

Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands

Motley Fool

Mon, 02/3/25 - 11:55 am

Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say

Forbes

Fri, 01/31/25 - 10:59 am

Novo Nordisk commences fresh trials for CagriSema

Devdiscourse

Thu, 01/30/25 - 11:33 am

clinical trials

FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD

Healio

Tue, 01/28/25 - 09:42 pm

Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial

Fierce Biotech

Tue, 01/28/25 - 10:17 am

Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35

MSN/Reuters

Mon, 01/27/25 - 10:51 pm

Pages